Chordate Medical Holding AB (CMH) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.514x

Based on the latest financial reports, Chordate Medical Holding AB (CMH) has a cash flow conversion efficiency ratio of -0.514x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-7.14 Million ≈ $-768.45K USD) by net assets (Skr13.90 Million ≈ $1.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CMH equity financing ratio to measure how much of total assets are equity-financed.

Chordate Medical Holding AB - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Chordate Medical Holding AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore Chordate Medical Holding AB cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Chordate Medical Holding AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chordate Medical Holding AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
FAT Brands Inc NASDAQ:FATBW	0.050x
RED LAKE GOLD INC. F:P11A	-1.043x
Ukrproduct Group LSE:UKR	0.310x
XLMedia PLC LSE:XLM	-0.008x
Vestand Inc. NASDAQ:VSTD	-0.192x
WICKET GAMING AB F:7Q4	0.015x
Futura Medical LSE:FUM	-0.940x
Blue Star Capital plc LSE:BLU	-0.049x

Annual Cash Flow Conversion Efficiency for Chordate Medical Holding AB (2015–2024)

The table below shows the annual cash flow conversion efficiency of Chordate Medical Holding AB from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Chordate Medical Holding AB worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr9.20 Million ≈ $989.55K	Skr-24.41 Million ≈ $-2.63 Million	-2.654x	-46.89%
2023-12-31	Skr15.09 Million ≈ $1.62 Million	Skr-27.26 Million ≈ $-2.93 Million	-1.807x	+19.89%
2022-12-31	Skr11.07 Million ≈ $1.19 Million	Skr-24.98 Million ≈ $-2.69 Million	-2.256x	-332.08%
2021-12-31	Skr38.95 Million ≈ $4.19 Million	Skr-20.34 Million ≈ $-2.19 Million	-0.522x	+23.19%
2020-12-31	Skr25.64 Million ≈ $2.76 Million	Skr-17.43 Million ≈ $-1.88 Million	-0.680x	+55.95%
2019-12-31	Skr10.98 Million ≈ $1.18 Million	Skr-16.95 Million ≈ $-1.82 Million	-1.543x	+8.48%
2018-12-31	Skr11.26 Million ≈ $1.21 Million	Skr-18.99 Million ≈ $-2.04 Million	-1.686x	-61.95%
2017-12-31	Skr18.24 Million ≈ $1.96 Million	Skr-18.99 Million ≈ $-2.04 Million	-1.041x	-219.15%
2016-12-31	Skr29.55 Million ≈ $3.18 Million	Skr-9.64 Million ≈ $-1.04 Million	-0.326x	+6.19%
2015-12-31	Skr35.72 Million ≈ $3.84 Million	Skr-12.42 Million ≈ $-1.34 Million	-0.348x	--

About Chordate Medical Holding AB

ST:CMH Sweden Medical Devices

Market Cap

$29.05K

Skr269.96K SEK

Market Cap Rank

#31564 Global

#748 in Sweden

Share Price

Skr0.10

Change (1 day)

-37.50%

52-Week Range

Skr0.10 - Skr9.00

All Time High

Skr439.49